Kinled invests in innovative businesses across the Life Science, Financial, and Digital Technology sectors. They have a long track record of financing deep technological breakthroughs, particularly in advanced medical devices, robotics, precision medicine, drug discovery, and neuromodulation. The firm's investment strategy includes both direct investments and fund investments, with a portfolio consisting of approximately 175 companies worldwide. They focus on early-stage businesses originating from universities in Europe and the United States, actively fostering innovation by maintaining offices and laboratories within university innovation parks and bio-campuses.
Bevorzugte Reifephase für die erste Finanzierung.
biomedical technology, medical devices, robotics, neuromodulation, digital healthcare services, SaaS-enabled networks and marketplaces, digital health, embedded payment platforms, insurance, real estate, lending, banking, fintech
Thematische Schwerpunkte und Zielmarktsegmente von Interesse.
Standard-Finanzierungsbetrag pro Runde.
Verifiziertes E-Mail-Muster
Analysen-Scorecard der Investitionsthese
Unser KI-Analyzer hat Portfolio-Unternehmen gescannt und verifizierte Übereinstimmungen berechnet...